Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-09 Purchase | 2022-08-11 4:08 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 115,000 | $7.5457 | $867,750 | 11,350,085 (Indirect) | View |
| 2022-08-08 Purchase | 2022-08-10 4:10 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 97,000 | $7.24 | $702,280 | 11,235,085 (Indirect) | View |
| 2022-08-05 Purchase | 2022-08-09 4:08 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 141,000 | $6.95 | $979,950 | 11,138,085 (Indirect) | View |
| 2022-08-04 Purchase | 2022-08-08 4:09 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 95,100 | $6.17 | $586,767 | 10,997,085 (Indirect) | View |
| 2022-08-03 Purchase | 2022-08-05 4:10 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 100,000 | $5.84 | $584,000 | 10,901,985 (Indirect) | View |
| 2022-08-02 Purchase | 2022-08-04 4:10 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 412,406 | $5.59 | $2,305,350 | 10,801,985 (Indirect) | View |
| 2022-08-01 Purchase | 2022-08-03 5:16 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 144,185 | $5.05 | $728,134 | 10,389,579 (Indirect) | View |
| 2022-07-29 Purchase | 2022-08-02 4:27 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 222,123 | $5.03 | $1,117,279 | 10,245,394 (Indirect) | View |
| 2022-07-28 Purchase | 2022-08-01 5:37 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 119,392 | $5 | $596,960 | 10,023,271 (Indirect) | View |
| 2022-06-23 Purchase | 2022-06-27 06:42 am | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 4,323 | $3.4755 | $15,025 | 23,967 (Direct) | View |
| 2022-06-23 Purchase | 2022-06-27 06:41 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 17,700 | $3.3642 | $59,546 | 1,216,535 (Direct) | View |
| 2021-05-03 Purchase | 2021-05-04 5:55 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 1,200,000 | $12.5 | $15,000,000 | 9,903,879 (Indirect) | View |
| 2021-01-19 Purchase | 2021-01-21 5:24 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 1,368,421 | $9.5 | $13,000,000 | 8,703,879 (Indirect) | View |
| 2021-01-07 Purchase | 2021-01-11 9:53 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 1,050,000 | $8.7644 | $9,202,668 | 7,335,458 (Indirect) | View |
| 2020-07-09 Purchase | 2020-07-13 4:30 pm | Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 3,200,000 | $4.25 | $13,600,000 | 6,285,458 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-07-15 Option Award | 2022-07-19 4:34 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 604,308 | $0 | 604,308 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-19 4:34 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks | 126,087 | $0 | 133,900 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-19 4:34 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 255,078 | $0 | 342,947 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 5:07 pm | N/A 2032-06-06 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 62,394 | $0 | 62,394 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 5:07 pm | N/A 2032-06-06 | Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director | 56,131 | $0 | 56,131 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 5:06 pm | N/A 2032-06-06 | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 61,930 | $0 | 61,930 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 5:06 pm | N/A 2032-06-06 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 61,002 | $0 | 61,002 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 5:06 pm | N/A 2032-06-06 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 69,353 | $0 | 69,353 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 5:04 pm | N/A 2032-06-06 | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 56,131 | $0 | 56,131 (Direct) | View |
| 2022-05-10 Ownership | 2022-05-13 4:28 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks | 0 | $0 | 333,685 (Direct) | View |
| 2022-03-30 Option Award | 2022-04-01 7:44 pm | N/A 2032-03-29 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 457,758 | $0 | 1,656,593 (Direct) | View |
| 2022-03-30 Option Award | 2022-04-01 7:37 pm | N/A 2032-03-29 | Aldeyra Therapeutics Inc. | ALDX | Reed Joshua CFO | 343,322 | $0 | 524,825 (Direct) | View |
| 2022-03-30 Option Award | 2022-04-01 7:37 pm | N/A 2032-03-29 | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 314,395 | $0 | 337,869 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 5:46 pm | N/A 2031-06-07 | Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director | 17,442 | $0 | 17,442 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 5:46 pm | N/A 2031-06-07 | Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director | 15,576 | $0 | 15,576 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 5:46 pm | N/A 2031-06-07 | Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director | 14,117 | $0 | 14,117 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 5:45 pm | N/A 2031-06-07 | Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director | 15,692 | $0 | 15,692 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 5:45 pm | N/A 2031-06-07 | Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director | 14,117 | $0 | 14,117 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 5:44 pm | N/A 2031-06-07 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 15,342 | $0 | 15,342 (Direct) | View |
| 2021-04-12 Option Award | 2021-04-14 7:25 pm | N/A 2031-04-11 | Aldeyra Therapeutics Inc. | ALDX | Reed Joshua CFO | 150,185 | $0 | 150,185 (Direct) | View |
| 2021-04-12 Option Award | 2021-04-14 7:24 pm | N/A 2031-04-11 | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 116,201 | $0 | 116,201 (Direct) | View |
| 2021-04-12 Option Award | 2021-04-14 7:23 pm | N/A 2031-04-11 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C CEO | 296,619 | $0 | 1,198,835 (Direct) | View |
| 2020-12-08 Ownership | 2020-12-18 6:06 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 0 | $0 | 325,635 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 5:51 pm | N/A 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director | 30,355 | $0 | 30,355 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 5:48 pm | N/A 2030-06-08 | Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director | 26,503 | $0 | 26,503 (Direct) | View |